Log in to download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Certificate Holder | Certificate No. | Substance | Issue Date | Status | Type | End Date | Substance No. |
|---|---|---|---|---|---|---|---|---|---|---|
| 31/10/2025 | Centrient Pharmaceuticals |
Netherlands |
CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL | CEP 2002-156 - Rev 06 | Cefadroxil monohydrate, Enzymatic process | 2024-08-22 | Valid | Chemical | 813 | |
| 31/10/2025 | TAPI Technology & API Services |
Israel |
Teva Pharmaceuticals Usa, Inc. Mexico US | R1-CEP 2005-091 - Rev 00 | Cefadroxil monohydrate | 2011-09-08 | Withdrawn by Holder | Chemical | 2025-08-12 | 813 |
